Rapid Double Antigen COVID-19 Screening test

Application

Detects Total antibodies ( IgM+IgA+IgG) antibodies to SARS-CoV-2 virus in human serum/plasma/whole blood

Principle A unique, self performing double antigen immunoassay on a membrane based on the principle of immunochromatography
Reagents
  •  Membrane assembly predispensed with
  1. SARS-CoV-2 virus specific recombinant antigen-indicator colloidal particles, streptavidin gold conjugate
  2. SARS-CoV-2 virus specific recombinant antigen-capture at test region ‘T’
  3. Biotinylated BSA at the control region ‘C’
Test duration Twenty minutes assay

Storage / Stability

4-30C, 18 months


Presentation

Pack

Cat.No.

Coviscreen™ kit contains individually pouched devices, sample droppers and sample running buffer

10 Tests

502080010

25 Tests 502080025